top of page

SPECIALTY

Quetiapine
Sustained Release Tablet 50 mg & 200 mg
Indication
1. Treatment of schizophrenia.
2. Acute treatment of manic or mixed episodes associated with bipolar I disorder, both as monotherapy and as an adjunct to lithium or divalproex.
3. Acute treatment of depressive episodes associated with bipolar disorder.
4. Maintenance treatment of bipolar I disorder, as an adjunct ot lithium or divalproex
5. Adjunctive therapy ot antidepressants for the treatment of Major Depressive Disorder (MDD)

Alliance Pharma Co.,Ltd.
Head Office : 128 (1st Floor),
Sutthisan Winitchai Road, Samsen Nok,
Huai Khwang, Bangkok, Thailand, 10310
Contact email: info@alliancepharma.co.th
Tel. 0-2513-7856 
Fax. 0-2513-7857
Working hours: Mon - Fri (8:30 AM - 5:00 PM)

  • Facebook - วงกลมสีขาว
  • LinkedIn
  • Youtube
kalbe logo for external usage.png
bottom of page